NICOX (EPA:COX) | Finanzwire

PRESS RELEASE

published on 09/04/2025 at 07:30, 4 months 25 days ago

Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
Nicox expects to fully repay financial debts in 2026 with NCX 470 de-risked and globally licensed, providing a financial update and strategic options. Milestones payable on NDA submissions and approvals

Strategic Options Nicox NCX 470 Financial Debts NDA Submissions
BRIEF

published on 08/26/2025 at 07:35, 5 months 3 days ago

Nicox launches FAQ page for shareholders

Shareholders Transparency Ophthalmology Nicox FAQ
PRESS RELEASE

published on 08/26/2025 at 07:30, 5 months 3 days ago

Nicox Announces Shareholder Q&A Webpage Available
Nicox introduces Q&A webpage for shareholders on nicox.com, addressing common queries about the company and its operations. Contact communications@nicox.com for investor queries

Shareholders Ophthalmology Nicox Q&A Webpage Investor Questions
BRIEF

published on 08/12/2025 at 15:58, 5 months 17 days ago

Soleus Capital Crosses Threshold in NICOX

Voting Rights Actions Threshold Crossing Nicox Soleus Capital
BRIEF

published on 08/08/2025 at 07:35, 5 months 21 days ago

Nicox Expands Equity Financing with Vester Finance

Equity Financing Nicox Share Dilution Phase 3 Results Vester Finance
PRESS RELEASE

published on 08/08/2025 at 07:30, 5 months 21 days ago

Nicox Extends Existing Flexible Equity Financing
Nicox extends PACEO equity line with Vester Finance by adding 5 million shares. NCX 470 Denali Phase 3 results expected in mid-August to mid-September 2025

Equity Financing Nicox Phase 3 Results NCX 470 Denali Vester Finance
BRIEF

published on 06/30/2025 at 07:35, 6 months 29 days ago

Nicox Achieves Milestone in NCX 470 Phase 3 Clinical Trial

Glaucoma Ocular Hypertension Phase 3 Trial Nicox NCX 470
PRESS RELEASE

published on 06/30/2025 at 07:30, 6 months 29 days ago

Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
Nicox announces completion of Denali Phase 3 trial for NCX 470 eye drop, expecting results mid-August to mid-September 2025. NDA submission in the U.S. targeted for H1 2026

Phase 3 Trial Ophthalmology Nicox NCX 470 NDA Submission
BRIEF

published on 06/06/2025 at 07:35, 7 months 23 days ago

Nicox Announces Shareholders’ Meeting and Ad Hoc Representative

Voting Rights Shareholders’ Meeting Euronext Growth Nicox Ad Hoc Representative
PRESS RELEASE

published on 06/06/2025 at 07:30, 7 months 23 days ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation

Published on 01/30/2026 at 00:00, 2 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 1 hour 2 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 5 hours 17 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 6 hours 2 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 7 hours 2 minutes ago

Sparta Reports on Delay in Filing Annual Financial Statements

View all ACCESSWIRE

Published on 01/29/2026 at 21:02, 3 hours ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 3 hours 1 minute ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 3 hours 3 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 3 hours 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/29/2026 at 20:57, 3 hours 5 minutes ago

2CRSi SA: Record first half: >€198m

View all EQS

Published on 01/29/2026 at 18:00, 6 hours 2 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 6 hours 17 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 6 hours 17 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 6 hours 22 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 13 hours 55 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE

News